Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas.

Bolander A, Agnarsdóttir M, Strömberg S, Ponten F, Hesselius P, Uhlen M, Bergqvist M.

Cancer Genomics Proteomics. 2008 Nov-Dec;5(6):293-300.

PMID:
19287070
[PubMed - indexed for MEDLINE]
Free Article
2.

Gene expression profiling of primary cutaneous melanoma and clinical outcome.

Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A; Melanoma Group of the European Organization for Research and Treatment of Cancer.

J Natl Cancer Inst. 2006 Apr 5;98(7):472-82.

PMID:
16595783
[PubMed - indexed for MEDLINE]
Free Article
3.

Association of galectin-3 expression with melanoma progression and prognosis.

Brown ER, Doig T, Anderson N, Brenn T, Doherty V, Xu Y, Bartlett JM, Smyth JF, Melton DW.

Eur J Cancer. 2012 Apr;48(6):865-74. doi: 10.1016/j.ejca.2011.09.003. Epub 2011 Nov 7.

PMID:
22071132
[PubMed - indexed for MEDLINE]
4.

Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanoma.

Berset M, Cerottini JP, Guggisberg D, Romero P, Burri F, Rimoldi D, Panizzon RG.

Int J Cancer. 2001 Jan 20;95(1):73-7.

PMID:
11241315
[PubMed - indexed for MEDLINE]
5.

Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.

Prieto VG, Mourad-Zeidan AA, Melnikova V, Johnson MM, Lopez A, Diwan AH, Lazar AJ, Shen SS, Zhang PS, Reed JA, Gershenwald JE, Raz A, Bar-Eli M.

Clin Cancer Res. 2006 Nov 15;12(22):6709-15.

PMID:
17121890
[PubMed - indexed for MEDLINE]
Free Article
6.

Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma.

Strömberg S, Agnarsdóttir M, Magnusson K, Rexhepaj E, Bolander A, Lundberg E, Asplund A, Ryan D, Rafferty M, Gallagher WM, Uhlen M, Bergqvist M, Ponten F.

J Proteome Res. 2009 Apr;8(4):1639-46. doi: 10.1021/pr800745e.

PMID:
19714869
[PubMed - indexed for MEDLINE]
7.

Prognostic value of galectin-3 in primary cutaneous melanoma.

Buljan M, Šitum M, Tomas D, Milošević M, Krušlin B.

J Eur Acad Dermatol Venereol. 2011 Oct;25(10):1174-81. doi: 10.1111/j.1468-3083.2010.03943.x. Epub 2010 Dec 22.

PMID:
21175876
[PubMed - indexed for MEDLINE]
8.

Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.

Chi DD, Merchant RE, Rand R, Conrad AJ, Garrison D, Turner R, Morton DL, Hoon DS.

Am J Pathol. 1997 Jun;150(6):2143-52.

PMID:
9176405
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Diagnostic and prognostic role of galectin 3 expression in cutaneous melanoma.

Abdou AG, Hammam MA, Farargy SE, Farag AG, El Shafey EN, Farouk S, Elnaidany NF.

Am J Dermatopathol. 2010 Dec;32(8):809-14. doi: 10.1097/DAD.0b013e3181e02f29.

PMID:
20885286
[PubMed - indexed for MEDLINE]
10.

Melastatin expression and prognosis in cutaneous malignant melanoma.

Duncan LM, Deeds J, Cronin FE, Donovan M, Sober AJ, Kauffman M, McCarthy JJ.

J Clin Oncol. 2001 Jan 15;19(2):568-76.

PMID:
11208852
[PubMed - indexed for MEDLINE]
11.

Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.

Nishizawa A, Nakanishi Y, Yoshimura K, Sasajima Y, Yamazaki N, Yamamoto A, Hanada K, Kanai Y, Hirohashi S.

Cancer. 2005 Apr 15;103(8):1693-700.

PMID:
15751018
[PubMed - indexed for MEDLINE]
Free Article
12.

Histological expression of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in human primary melanoma.

Bron LP, Scolyer RA, Thompson JF, Hersey P.

Pathology. 2004 Dec;36(6):561-5.

PMID:
15841691
[PubMed - indexed for MEDLINE]
13.

Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.

Boyd AS, Shakhtour B, Shyr Y.

J Am Acad Dermatol. 2008 May;58(5):750-4. doi: 10.1016/j.jaad.2007.12.026. Epub 2008 Feb 4.

PMID:
18249467
[PubMed - indexed for MEDLINE]
14.

SOX10 expression in superficial spreading and nodular malignant melanomas.

Agnarsdóttir M, Sooman L, Bolander A, Strömberg S, Rexhepaj E, Bergqvist M, Ponten F, Gallagher W, Lennartsson J, Ekman S, Uhlen M, Hedstrand H.

Melanoma Res. 2010 Dec;20(6):468-78. doi: 10.1097/CMR.0b013e3283403ccd.

PMID:
20890226
[PubMed - indexed for MEDLINE]
15.

Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.

Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8606-14.

PMID:
16361544
[PubMed - indexed for MEDLINE]
Free Article
16.

Immunohistochemically detectable bcl-2 expression in metastatic melanoma: association with survival and treatment response.

Vlaykova T, Talve L, Hahka-Kemppinen M, Hernberg M, Muhonen T, Collan Y, Pyrhönen S.

Oncology. 2002;62(3):259-68.

PMID:
12065874
[PubMed - indexed for MEDLINE]
17.

Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.

Busam KJ, Iversen K, Berwick M, Spagnoli GC, Old LJ, Jungbluth AA.

Mod Pathol. 2000 Apr;13(4):459-65.

PMID:
10786815
[PubMed - indexed for MEDLINE]
Free Article
18.

Ets-1 transcription factor is widely expressed in benign and malignant melanocytes and its expression has no significant association with prognosis.

Torlakovic EE, Bilalovic N, Nesland JM, Torlakovic G, Flørenes VA.

Mod Pathol. 2004 Nov;17(11):1400-6.

PMID:
15205685
[PubMed - indexed for MEDLINE]
Free Article
19.

Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance.

Nambiar S, Mirmohammadsadegh A, Hassan M, Mota R, Marini A, Alaoui A, Tannapfel A, Hegemann JH, Hengge UR.

Carcinogenesis. 2007 Dec;28(12):2501-10. Epub 2007 Sep 3.

PMID:
17768177
[PubMed - indexed for MEDLINE]
Free Article
20.

Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.

Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, Lin A, Kluger HM, Berger AJ, Cheng E, Trombetta ES, Wu T, Niinobe M, Yoshikawa K, Hannigan GE, Halaban R.

Cancer Res. 2004 Aug 1;64(15):5270-82.

PMID:
15289333
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk